Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126181051 | 12618105 | 1 | I | 20160726 | 20160726 | 20160803 | 20160803 | PER | US-JNJFOC-20160723713 | JANSSEN | 81.00 | YR | E | F | Y | 78.93000 | KG | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126181051 | 12618105 | 1 | PS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | IN THE MORNING | U | U | 19835 | 2 | DF | UNSPECIFIED | |||||
| 126181051 | 12618105 | 2 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | IN THE MORNING | U | U | 19835 | 2 | DF | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126181051 | 12618105 | 1 | Adverse drug reaction |
| 126181051 | 12618105 | 2 | Pruritus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126181051 | 12618105 | Drug administration error | |
| 126181051 | 12618105 | Incorrect dose administered | |
| 126181051 | 12618105 | Off label use | |
| 126181051 | 12618105 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126181051 | 12618105 | 1 | 20160726 | 0 | ||
| 126181051 | 12618105 | 2 | 20160726 | 0 |